This may be due to the lower adiponectin concentration in the ADIPOQ rs182052 GG genotype than in the GA/AA genotype, while at the same time diabetic patients had lower adiponectin, resulting in a higher OR of CKD, which was not observed in non-diabetic patients (normal adiponectin). This evidence concerns the gene ADIPOQ and chronic kidney disease.